30 minutes | Jan 13, 2021

4. The Curious Case of the Adenoviral Vector Vaccines

Adenoviral vector vaccines are seen as the vaccine for the world given that they are cheaper to produce and easier to distribute versus mRNA vaccines. We learn about their development in the lab and challenges that have been overcome, while experts discuss possible roadblocks of pre-existing immunity that may impact future efficacy. While AstraZeneca's confusing interim results get dissected, experts look ahead to results from Johnson & Johnson's single shot vaccine, which could be a pandemic game changer if successful. Finally, experts discuss the safety of these vaccines especially after both AstraZeneca and Johnson & Johnson’s trials had to be paused for safety last year. Guest profiles and timestamps available at https://thecovaxfiles.com
Play Next